Clinuvel Pharmaceuticals Ltd (CUV) — Long-term Investment Intensity
Clinuvel Pharmaceuticals Ltd (CUV) has a Long-term Investment Intensity of 0.1% as of June 2025. Long-term investments of AU$213.34K represent 0.1% of total assets of AU$271.75 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Clinuvel Pharmaceuticals Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Clinuvel Pharmaceuticals Ltd Long-term Investment Intensity (2024–2025)
This chart shows how Clinuvel Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2025, the intensity stands at 0.1%, reflecting long-term investments of AU$213.34K against total assets of AU$271.75 Million AUD. For the complete balance sheet picture, see Clinuvel Pharmaceuticals Ltd total assets.
Annual Long-term Investment Intensity for Clinuvel Pharmaceuticals Ltd (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Clinuvel Pharmaceuticals Ltd from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Clinuvel Pharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.1% | AU$213.34K | AU$271.75 Million | ▲ +0.0 pp |
| 2024 | 0.1% | AU$134.21K | AU$231.12 Million | — |